MedPath

Estimating microRNA levels in periodontal disease and their response to non-surgical therapy.

Not Applicable
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2021/09/036784
Lead Sponsor
Panineeya Mahavidyalaya Institute of Dental Sciences and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Stage II and Stage III periodontitis patients (4-6mm pocket depth or 3-5 mm loss of attachment) according to the AAP Classification 2018.

2.Patients who have not received periodontal therapy, within preceding six months.

Exclusion Criteria

1.Patients who received treatment with antibiotics/anti-inflammatory drugs in last 3 months.

2.Pregnant and lactating females.

3.Medically compromised patients.

4.Smokers, tobacco chewers and alcoholics.

5.Patients taking high-dose steroid therapy, radiation or immunosuppressive therapy.

6.Mentally retarded and un-cooperative patients.

7.Known history of genetic disorders.

8.Patients not compliant to oral hygiene instructions and recall maintenance.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evels of salivary and serum microRNA 146a, 200c and PTEN gene.Timepoint: Baseline and 8 weeks
Secondary Outcome Measures
NameTimeMethod
1.Sulcus bleeding index ( Muhlemann and Son, 1971) <br/ ><br>2.Plaque Index ( Turesky, Gilmore, Glickman modification of Quigley-Hein Plaque Index, 1970) <br/ ><br>3.Probing Pocket Depth(PPD) <br/ ><br>4.Clinical Attachment Loss(CAL)Timepoint: Baseline and 8 weeks
© Copyright 2025. All Rights Reserved by MedPath